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Background: Although attention to metabolic syndrome (MetS) in children has increased, there is still no
universally accepted definition and its pathogenesis remains unclear. Our aim was to compare the current
definitions of childhood MetS in a Chinese cohort and to examine the clustering pattern of MetS risk factors,
particularly inclusion of leptin and adiponectin as additional components.
Methods: 3373 schoolchildren aged 6 to 18 years were recruited. Anthropometric and biochemical parameters and
adipokines were measured. MetS was identified using both the International Diabetes Federation (IDF) and a
modified Adult Treatment Panel III (ATP III) definitions. Exploratory factor analysis was performed to establish
grouping of metabolic characteristics.
Results: For children ≥10 years, the prevalence of MetS was 14.3% in the obese group and 3.7% in the overweight
group according to the new IDF definition, and 32.3% in the obese group and 8.4% in the overweight group
according to the modified ATPIII definition. Frequency of hypertriglyceridemia, low high-density lipoprotein
cholesterol (HDL-C), impaired fasting glucose, elevated blood pressure, and central obesity according to the new
IDF definition was 16.7%, 20.7%, 15.8%, 25.5% and 75.5% in obese boys and 14.7%, 24.0%, 12.0%, 11.0% and 89.0%
in obese girls, respectively. Metabolic abnormalities in children under 10 years of age were also noted. Using factor
analysis on eight conventional variables led to the extraction of 3 factors. Waist circumference (WC) provided a
connection between two factors in boys and all three factors in girls, suggesting its central role in the clustering of
metabolic risk factors. Addition of leptin and adiponectin also led to the extraction of 3 factors, with leptin
providing a connection between two factors in girls. When using WC, mean arterial pressure, triglyceride/HDL-C
ratio, HOMA-IR and leptin/adiponectin ratio as variables, a single-factor model was extracted. WC had the biggest
factor loading, followed by leptin/adiponectin ratio.
Conclusions: MetS was highly prevalent amongst obese children and adolescents in this cohort, regardless of the
definition used. Central obesity is the key player in the clustering of metabolic risk factors in children, supporting
the new IDF definition. Moreover, our findings suggest that a common factor may underlie MetS. Leptin/
adiponectin ratio as a possible component of MetS deserves further consideration.* Correspondence: liming@pumch.cn
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Metabolic syndrome (MetS) refers to a combination of
metabolic disturbances associated with type 2 diabetes
mellitus (T2DM) and cardiovascular disease (CVD) [1].
In recent years, interest in childhood MetS has increased
substantially due to the increasing prevalence of child-
hood obesity on a global scale. However, research in this
area has been difficult in view of lack of a well-accepted
definition of childhood MetS [2]. So far, most definitions
have been adapted from the Adult Treatment Panel III
(ATP III) definition [1], represented by the most com-
monly used version published by Cook et al. [2,3]. In
order to estimate the global prevalence of MetS and
make valid comparisons between nations, the Inter-
national Diabetes Federation (IDF) released its definition
of MetS in children and adolescents in 2007 (i.e., IDF
2007 definition) [4]. However, this definition has not yet
been fully evaluated in different ethnic groups [5,6].
Recently, expansion of the definition to include other
components such as adipokines and inflammatory marker
levels has been considered [6]. It has been suggested that
dysregulation of circulating adipokine levels may provide
a link between obesity and insulin resistance, thereby
influencing the development of MetS and vascular com-
plications [7]. Leptin and adiponectin are the two
major adipokines secreted by adipocytes, and have been
recommended as adipose tissue biomarkers by IDF in
their “platinum standard” definition of MetS for research
[4]. Most studies have demonstrated that hyperleptinemia
and hypoadiponectinemia are associated with the occur-
rence of T2DM, hypertension, dyslipidemia, MetS and
CVD [7-14]. Moreover, some studies suggest that leptin/
adiponectin ratio can be used as a potential atherogenic
index [15] and provides adjunctive information for the risk
of MetS [16]. However this has not been well studied in
pediatric populations.
Although visceral obesity and insulin resistance appear
to be at the core of the development of MetS, due to in-
creasing numbers of metabolic risk factors and the com-
plex interaction between the different components, the
underlying pathogenesis of MetS remains unclear
[2,4-6]. Factor analysis provides a means of condensing
large numbers of highly intercorrelated variables into a
few composite factors, thus allowing investigators to
overcome analytic challenges, and help define the under-
lying structure [17]. Many studies [9-11,13,17-22] have
used exploratory factor analysis to examine the associa-
tions between traditional and emerging risk factors con-
sidered to be potential components of MetS. However,
with different components being used, so far no consist-
ent conclusion has been reached. In recent years, it has
been suggested that a one-factor model provided better
understanding of MetS in studies using confirmatory
factor analysis [23-25]. However, little is known aboutwhether this one-factor model could be expanded to in-
clude other risk factors such as adipokine levels.
As there is so far no consensus over the definition of
childhood MetS, we measured the prevalence of MetS in
children and adolescents in Beijing, using both the new
IDF definition and a modified ATPIII definition. Fur-
thermore, based on data collected in the Beijing Child
and Adolescent Metabolic Syndrome (BCAMS) study
[26], we performed exploratory factor analysis on the
various MetS components to characterize the clustering
pattern and examine the role of leptin and adiponectin
in the clustering of metabolic risk factors.
Methods
Subjects
Subjects were recruited from a cross-sectional popula-
tion-based survey: the BCAMS cohort study [26,27]. A
total of 3373 schoolchildren (1717 boys) were included
in the current study, among them 637 were overweight
and 1195 were obese. Age- and sex-specific body mass
index (BMI) percentiles, developed by the Working
Group for Obesity in China, were used to classify partic-
ipants as normal weight (BMI <85%), overweight (BMI
≥85% but <95%), or obese (BMI ≥ 95%) [28]. Signed in-
formed consent was obtained from participants and/or
parents/guardians. The BCAMS study was approved by
the Ethics Committee at the Capital Institute of
Pediatrics in Beijing.
Clinical and anthropometric measurements
Subjects’ height and weight were measured according to
our standard protocol [28]. BMI was calculated as
weight (kg) divided by height squared (m2). Waist cir-
cumference (WC) was measured midway between the
lowest rib and the top of the iliac crest. The mean of 2
measurements made at the end of a normal expiration
was used in the analyses. Two measurements of right
arm systolic and diastolic blood pressure (SBP and DBP)
were performed 3 times 10 minutes apart and the mean
values of the latter 2 measurements were recorded. Pu-
bertal development was assessed by Tanner stage of
breast development in girls and testicular volume in
boys [29]. Children with Tanner stage >1 were consid-
ered pubertal. This assessment was performed visually
by two pediatricians of the same gender as the child.
Laboratory measurement
Venous blood samples were collected after an overnight
(≥12 h) fast. The samples were centrifuged, aliquoted and
immediately frozen for future analysis of lipids and
hormones. Blood samples were also analyzed for con-
centrations of plasma glucose, triglycerides (TG), total
cholesterol (TC), high-density lipoprotein cholesterol
(HDL-C), low-density lipoprotein cholesterol (LDL-C),
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methods) and plasma glucose (glucose oxidase method)
were assayed using the Hitachi 7060 C automatic biochem-
istry analysis system. HDL-C and LDL-C were measured
directly. Insulin was measured by monoclonal antibody-
based sandwich enzyme-linked immunosorbent assay
(ELISA) [30], developed in the Key Laboratory of Endocrin-
ology, Peking Union Medical College Hospital which had
an inter-assay coefficients of variation (CV) of <9.0% and
no cross-reactivity to proinsulin (<0.05%). Serum adi-
ponectin was measured by ELISA with intra-assay and
inter-assay CV of <5.4% and <8.5%, respectively; while
serum leptin was measured by ELISA with intra-assay and
inter-assay CV of <7.4% and <9.3%, respectively [26,31].
Definitions
For this study, the presence of pediatric MetS was deter-
mined according to both the IDF 2007 definition [4] and a
modified ATPIII definition [3,26] for comparison. The IDF
2007 definition was applied differently to different age
groups: 6 to <10, 10 to <16, and ≥16 years. For children
aged 10 to <16 years, a diagnosis of MetS was made as the
presence of abdominal obesity (WC ≥ 90th percentile for
age and gender or adult cut-off if lower) plus the presence
of two or more of the other components: elevated TG
(≥1.7 mmol/L), low HDL-C (<1.03 mmol/L), high blood
pressure (systolic ≥130 mmHg or diastolic ≥85 mmHg),
and elevated blood glucose (≥ 5.6 mmol/L). IDF criteria
for adults [4] were used to identify MetS in those
aged ≥16 years. Although the IDF definition was not
intended to be applied to children below 10 years of age,
for the purposes of this study to enable comparisons to be
made, we have defined the individual risk components of
MetS as for children aged between 10 to <16 years [4,32].
For comparison, a modified ATPIII definition was also
employed in which MetS was defined by the presence of
three or more of the following five components [3,26]:
(1) central obesity defined as WC ≥ 90th percentile for
age and gender (established based on the BCAMS
study); (2) elevated systolic and/or diastolic blood pres-
sure ≥ 90th percentile for age, sex and height (according
to the BCAMS study); (3) hypertriglyceridemia defined
as TG ≥1.24 mmol/L, equal to the 90th percentile of the
reference population; (4) low serum HDL-C (Low-HDL)
defined as ≤1.03 mmol/L i.e., ≤ 5th percentile of the ref-
erence population and (5) impaired fasting glucose (IFG)
defined as ≥ 5.6 mmol/L.
Insulin resistance index was calculated by homeostasis
model assessment of insulin resistance (HOMA-IR) as
(fasting insulin IU/L) × (fasting glucose mmol/L)/22.5. In-
sulin resistance was defined as HOMA-IR ≥3.0, i.e., ≥95th
percentile of the reference population (subjects without
any of the “conventional” MetS components from the
BCAMS study). Hyperleptinemia was defined as leptin ≥95th percentile and hypoadiponectinemia was defined as
adiponectin ≤ 5th percentile for gender of the same refer-
ence population.
Statistical analysis
Data were analyzed using SPSS for Windows 15.0 (SPSS
Inc., Chicago, IL, USA). All skewed distributions were
log transformed for analysis. Results are expressed as
mean ± standard deviation (SD) or percentage (%) as ap-
propriate. The mean values of variables studied were
compared between normal weight, overweight and obese
groups by analysis of variance (ANOVA) and post hoc
analysis. Prevalence of individual metabolic abnormal-
ities of different groups was compared using the χ2 test
or Fisher’s exact test as appropriate. Correlations were
calculated using Pearson correlation coefficient.
According to previous studies [17,33,34], exploratory
factor analysis is well suited for determining the cluster-
ing patterns of MetS components and helping suggest
underlying pathophysiology. Exploratory factor analysis
was performed using principal component analysis, a
technique for reducing the number of original variables
into fewer latent factors. The factors are created by a
scoring algorithm such that individual variables “load”
most strongly onto the factor with which they are most
correlated. The factor loading of a variable on a factor
equals the Pearson correlation coefficient between that
variable and the factor. Thus, higher factor loadings rep-
resent more correlation between the variable and the la-
tent factor. In MetS, if the analysis reveals only one
underlying factor, this may be interpreted as supporting
the theory that one unifying physiology accounts for the
metabolic risk variables clustering, thus favoring a com-
mon pathogenesis. The unity hypothesis would be less
probable if more than one factor is found. However, if a
measured risk variable is associated with more than one
factor, this overlap reveals unifying commonalties be-
tween physiologic domains. Thus, the patterns of overlap
could provide valuable insights into the underlying
structure of the syndrome [17,22,33].
Factor analysis includes three steps : (1) factor extrac-
tion, which produces the minimum number of factors
that retain as much of the total variance in the original
data as possible; (2) varimax rotation to make factors
more readily interpretable; and (3) interpretation based
on rotated factor loadings. In this study, factors with an
eigenvalue (the amount of variance attributable to the
factor) of greater than one were extracted. Factor load-
ings of ≥ |0.40| were considered meaningful for inter-
pretation, because this ensures that the variable shares
at least 15% of the variance with the factor [17.25]. The
analysis was performed first on the conventional meta-
bolic variables (WC, DBP, SBP, HOMA-IR, insulin, glu-
cose, TG and HDL-C) and subsequently with the
Wang et al. BMC Public Health 2013, 13:249 Page 4 of 12
http://www.biomedcentral.com/1471-2458/13/249addition of leptin and adiponectin. Since factor analysis
extracts factors due to the interrelatedness of measured
variables, using two or more measures for the same trait
(e.g. SBP and DBP, TG and HDL-C) would increase the
number of factors found [24,33]. We then used one par-
ameter for each of the postulated MetS components: WC
for central obesity and mean arterial pressure (MAP) for
blood pressure, TG/HDL-C ratio for dyslipidemia trait,
and HOMA-IR for insulin resistance. Using these three
composite parameters along with WC, a third factor ana-
lysis was performed. After that, leptin/adiponectin ratio
was employed as an additional component for the fourth
factor analysis. Bartlett’s test of sphericity was used to
examine the appropriateness of using factor analysis. In




Anthropometric and metabolic parameters of the study
population by gender and BMI classification are pre-
sented in Table 1. This study included 3373 children and
adolescents (1717 boys, 1656 girls) aged 6–18 years. The
mean ages ± SD of boys and girls were 11.8 ± 3.0 and
12.2 ± 3.0 years, respectively (P < 0.001). More boys were
obese than girls (P < 0.001). Compared to the normal
weight group, mean WC, SBP, DBP, TG, insulin andTable 1 Characteristics of the study population according to
Boys
Normal weight Overweight O
N 629 319
Age (ys) 11.7 ± 3.1a 12.7 ± 3.1b 11
Tanner stage 2.1 ± 1.2a 2.6 ± 1.3b 2.
BMI (kg m-2) 17.7 ± 2.4a 23.3 ± 2.7b 26
WC (cm) 63.3 ± 7.6a 78.2 ± 8.8b 86.
SBP (mm Hg) 103 ± 13a 114 ± 14b 11
DBP (mm Hg) 64 ± 10a 70 ± 10b 7
TC (mmol/L) 4.03 ± 0.84 4.03 ± 0.76 4.1
TG (mmol/L)# 0.79 ± 0.39a 1.08 ± 0.58b 1.2
HDL-C (mmol/L) 1.55 ± 0.36a 1.33 ± 0.32b 1.2
LDL-C (mmol/L) 2.40 ± 0.76a 2.52 ± 0.67a 2.6
Glucose (mmol/L) 5.12 ± 0.66 5.17 ± 0.47 5.1
Insulin (mU/L) # 6.2 ± 4.3a 10.6 ± 7.7b 14.
HOMA-IR# 1.42 ± 1.01a 2.50 ± 2.09b 3.5
Leptin (ng/ml)# 1.7 ± 2.5a 7.9 ± 9.1b 15.
Adiponectin (μg/L)# 15.1 ± 8.7a 11.4 ± 7.3b 10
Leptin/Adiponectin# 0.18 ± 0.39a 0.95 ± 1.24b 2.0
Abbreviations: BMI body mass index, WC waist circumference, SBP systolic blood pr
C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, HO
leptin-to-adiponectin ratio. Data are expressed as mean ± SD. #Skewed distributions
with different superscript letters (e.g. a, b, c) are significantly different, with p < 0.05HOMA-IR were significantly higher, while HDL-C was
significantly lower in obese children. As BMI increased,
so did leptin concentrations and leptin/adiponectin
ratios.
Prevalence of MetS and individual MetS abnormalities
As the IDF definition suggests that MetS should not be
diagnosed below the age of 10 years (4), we have divided
our population into two groups for analysis: ≥ 10 years,
and <10 years. Gender-specific prevalence of individual
MetS abnormalities by BMI category according to both
the IDF 2007 and modified ATPIII definitions was esti-
mated (Table 2 and Table 3).
For girls and boys older than 10 years, prevalence of
MetS was 14.3% in the obese group and 3.7% in the over-
weight group according to the IDF 2007 definition. Central
obesity was the most common abnormality in obese chil-
dren in both genders, followed by elevated blood pressure
in boys and Low-HDL in girls. According to the modified
ATPIII definition, prevalence of MetS was 32.3% in obese
children and 8.4% in the overweight, respectively. The
most common component of MetS was still central obes-
ity, followed by hypertriglyceridemia and elevated blood
pressure in boys and girls, respectively. Apart from the
normal weight group of boys, prevalence of MetS differed
significantly depending on which of the two definitions
was used for diagnosis. Prevalence of other metabolicBMI category in boys and girls
Girls
bese Normal weight Overweight Obese
769 912 318 426
.4 ± 2.9a 12.3 ± 3.1a 12.9 ± 2.9b 11.2 ± 2.9c
1 ± 1.2a 3.1 ± 1.3a 3.8 ± 1.4b 3.1 ± 1.5a
.9 ± 3.6c 18.0 ± 2.4a 23.4 ± 2.3b 25.9 ± 3.8c
1 ± 10.8c 62.1 ± 6.6a 74.0 ± 6.3b 79.5 ± 9.7c
6 ± 13c 101 ± 12a 109 ± 10b 111 ± 11c
2 ± 9c 64 ± 9a 69 ± 8b 71 ± 9c
1 ± 0.75 4.18 ± 0.86a 4.05 ± 0.77b 4.04 ± 0.73b
0 ± 0.63c 0.96 ± 0.50a 1.05 ± 0.54b 1.18 ± 0.63c
7 ± 0.26c 1.52 ± 0.30a 1.34 ± 0.26b 1.26 ± 0.26c
5 ± 0.66b 2.56 ± 0.80 2.56 ± 0.70 2.58 ± 0.66
9 ± 0.48 4.96 ± 0.44a 5.15 ± 1.02b 5.11 ± 0.50b
8 ± 13.9c 7.3 ± 4.9a 11.6 ± 6.9b 15.4 ± 12.5c
2 ± 3.80c 1.65 ± 1.20a 2.67 ± 1.62b 3.57 ± 3.34c
6 ± 12.3c 5.3 ± 5.8a 14.6 ± 10.8b 20.5 ± 14.0c
.3 ± 5.8b 15.0 ± 7.8a 11.5 ± 5.8b 10.6 ± 5.3b
4 ± 1.99c 0.55 ± 0.95a 1.74 ± 2.21b 2.63 ± 2.83c
essure, DBP diastolic blood pressure, TC total cholesterol, TG triglycerides, HDL-
MA-IR homeostatic model assessment of insulin resistance, leptin/adiponectin
were logarithmically transformed for one-way ANOVA. Values in the same row
(one-way ANOVA between normal-weight vs. overweight vs. obese groups).
Table 2 Prevalence of individual metabolic components in children ≥ 10 years according to BMI category
IDF 2007 definition Modified ATPIII definition
Normal weight Overweight Obese P Normal weight Overweight Obese P
Boys (n) 464 269 546 464 269 546
Hyper-TG 13(2.8%) 34(12.6%) 91(16.7%) <0.001 43(9.3%) 82(30.5%) 205(37.5%) <0.001
Low-HDL 24(5.2%) 40(14.9%) 113(20.7%) <0.001 26(5.6%) 42(15.6%) 120(22.0%) <0.001
IFG 74(15.9%) 39(14.5%) 86(15.8%) NS 74(15.9%) 39(14.5%) 86(15.8%) NS
Elevated BP 22(4.7%) 36(13.4%) 139(25.5%) <0.001 32(6.9%) 54(20.1%) 202(37.0%) <0.001
Central obesity 0 30(11.2%) 412(75.5%) <0.001 0 41(15.2%) 416(76.2%) <0.001
MetS (%) 0 7(2.6%) 80(14.7%) <0.001 2(0.4%) 22(8.2%) 184(33.7%) <0.001
Girls (n) 725 268 292 725 268 292
Hyper-TG 54(7.4%) 29(10.8%) 43(14.7%) 0.002 151(20.8%) 66(24.6%) 102(34.9%) <0.001
Low-HDL 63(8.7%) 52(19.4%) 70(24.0%) <0.001 32(4.4%) 31(11.6%) 55(18.8%) <0.001
IFG 56(7.7%) 33(12.3%) 35(12.0%) 0.029 56(7.7%) 33(12.3%) 35(12.0%) 0.029
Elevated BP 16(2.2%) 10(3.7%) 32(11.0%) <0.001 61(8.4%) 44(16.4%) 104(35.6%) <0.001
Central obesity 8(1.1%) 96(35.8%) 260(89.0%) <0.001 8(1.1%) 110(41.0%) 260(89.0%) <0.001
MetS (%) 0 13(4.9%) 40(13.7%) <0.001 10(1.4%) 24(9.0%) 89(30.5%) <0.001
Abbreviations: IDF International Diabetes Federation, ATPIII Adult Treatment Panel III, Hyper-TG Hypertriglyceridemia, Low-HDL low serum HDL cholesterol, IFG
impaired fasting glucose, BP Blood pressure, MetS Metabolic syndrome.
Prevalence of individual metabolic component was estimated using the IDF 2007 and the modified ATPIII definitions. The IDF definition for children from 10 to
16 years included the presence of central obesity (WC ≥ 90th percentile) plus two of the other four factors: (1) Hyper-TG with fasting TG ≥1.7 mmol/L, (2) Low-HDL
with HDL-C <1.03 mmol/L, (3) hypertension with SBP ≥ 130 and/or DBP ≥ 85 mm Hg, (4) IFG with fasting glucose ≥ 5.6 mmol/L. IDF criteria for adults were used to
define MetS in those aged ≥16 years. The modified ATPIII definition for children was defined by the presence of three or more of the following five components:
(1) central obesity (WC ≥ 90th percentile), (2) elevated SBP and/or DBP ≥ 90th percentile, (3) fasting TG ≥ 1.24 mmol/L, (4) HDL-C ≤ 1.03 mmol/L, and (5)
fasting glucose ≥ 5.6 mmol/L.
Results are expressed as number with percentage (%). Significance was calculated by χ2 test or Fisher’s exact test among normal weight, over weight and obese
groups in both genders.
Table 3 Prevalence of individual metabolic components in children<10 years according to BMI category
IDF 2007 definition Modified ATPIII definition
Normal weight Over-weight Obese P Normal weight Over-weight Obese P
Boys (n) 165 50 223 165 50 223
Hyper-TG 7(4.2%) 5(10.0%) 34(15.2%) 0.002 16(9.7%) 10(20.0%) 73(32.7%) <0.001
Low-HDL 2(1.2%) 2(4.0%) 14(6.3%) 0.043 2(1.2%) 2 (4.0%) 14(6.3%) 0.034
IFG 18(10.9%) 9(18.0%) 33(14.8%) NS 18(10.9%) 9 (18.0%) 33(14.8%) NS
Elevated BP 4(2.4%) 1(2.0%) 15(6.7%) NS 14(8.5%) 6(12.0%) 60(26.9%) <0.001
Central obesity 4(2.4%) 5(10.0%) 181(81.2%) <0.001 4(2.4%) 5(10.0%) 181(81.2%) <0.001
MetS (%) 0 0 14(6.3%) <0.001 2(1.2%) 3(6.0%) 42(18.8%) <0.001
Girls (n) 187 50 134 187 50 134
Hyper-TG 6(3.2%) 1(2.0%) 13(9.7%) 0.032 23(12.3%) 8(16.0%) 43(32.1%) <0.001
Low-HDL 6(3.2%) 4(8.0%) 16(11.9%) 0.008 7(3.7%) 4 (8.0%) 18(13.4%) 0.005
IFG 3(1.6%) 5(10.0%) 10(7.5%) 0.005 3(1.6%) 5 (10.0%) 10(7.5%) 0.005
Elevated BP 5(2.7%) 3(6.0%) 6(4.5%) NS 17(9.1%) 11 (22.0%) 38(28.4%) <0.001
Central obesity 8(4.3%) 21(42.0%) 114(85.1%) <0.001 8(4.3%) 21 (42.0%) 114(85.1%) <0.001
MetS (%) 0 0 8(6.0%) <0.001 2(1.1%) 0 36(26.9%) <0.001
Abbreviations: IDF International Diabetes Federation, ATPIII Adult Treatment Panel III, Hyper-TG Hypertriglyceridemia, Low-HDL low serum HDL cholesterol, IFG
impaired fasting glucose, BP Blood pressure, MetS metabolic syndrome.
Prevalence of individual metabolic component in these children aged below 10 years was estimated using the IDF definition for children aged 10 to 16 years and
the modified ATPIII definitions, respectively. The IDF definition for children from 10 to 16 years included the presence of central obesity (WC ≥ 90th percentile)
plus two of the other four factors: (1) Hyper-TG with fasting TG ≥1.7 mmol/L, (2) Low-HDL with HDL-C <1.03 mmol/L, (3) hypertension with SBP ≥ 130 and/or
DBP ≥ 85 mm Hg, (4) IFG with fasting glucose ≥ 5.6 mmol/L. The modified ATPIII definition for children was defined by the presence of three or more of the
following five components: (1) central obesity (WC ≥ 90th percentile), (2) elevated SBP and/or DBP ≥ 90th percentile, (3) fasting TG ≥ 1.24 mmol/L, (4) HDL-C ≤ 1
.03 mmol/L, and (5) fasting glucose ≥ 5.6 mmol/L. Results are expressed as number with percentage (%). Significance was calculated by χ2 test or Fisher’s exact
test among normal weight, over weight and obese groups in both genders.
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and hypoadipotinemia, also increased significantly with in-
crease in body weight, with the highest percentages in the
obese group (52.5%, 81.2% and 16% respectively) (see
Additional file 1).
For children < 10 years of ages, according to the ATPIII
definition, the prevalence of MetS in obese group was still
high (18.8% in boys and 26.9% in girls) (Table 3). To pro-
vide a comparison, we also used the IDF definition for
children aged 10 to 16 years to estimate the metabolic ab-
normalities; the prevalence of MetS in the obese group
dropped to 6.2% (Table 3). In addition, prevalence of
hyperleptinemia was 83.4% and 46.3% in obese boys and
girls, respectively; while prevalence of insulin resistance
was 20.2% and 22.4%, respectively, which was much lower
than in older children (see Additional file 1).
Analysis of correlation
The correlation matrix between the variables of interest
is shown in Additional file 1. Serum leptin level was sig-
nificantly associated with all conventional variables of
MetS, especially WC and insulin in both genders. Serum
adiponectin level had positive correlation with HDL-C
and negative correlation with WC, TG, SBP and DBP in
boys as well as girls. WC had the strongest association
with leptin/adiponectin and was strongly associated with
leptin, insulin, HOMA-IR, HDL-C, SBP and DBP in
both genders. Apart from insulin, WC and leptin had
the strongest positive correlation with HOMA-IR in
boys and girls respectively. Considering lipid parameters
in both genders, HDL-C had the strongest positive and
negative correlation with adiponectin and WC, respect-
ively, while TG had the strongest positive correlation
with leptin/adiponectin.
Exploratory factor analysis
Table 4 provides the results of the factor analysis with
and without leptin and adiponectin as variables in both
genders. Entering the conventional components of MetS
(WC, SBP, DBP, TG, HDL-C, glucose, HOMA-IR and in-
sulin), exploratory factor analysis extracted three factors
with some differences in both genders (accounting for
76.8% and 73.0% of the total variance in boys and girls,
respectively). In boys, WC, TG, HOMA-IR and insulin
contributed positively on factor 1, and HDL-C contrib-
uted negatively on this factor. WC, SBP and DBP had
positive contributions on factor 2. HOMA-IR, insulin
and glucose showed positive contributions to factor 3. In
girls, TG, HDL-C, HOMA-IR and insulin were not
loaded together, but on factor 1 and 3 separately. WC
together with HOMA-IR, insulin and glucose consti-
tuted the first factor which accounted for the largest
proportion of the total variance in girls. Similar to boys,
factor 2 was mainly determined by SBP, DBP and WC.Notably, WC was loaded on two of the three factors in
boys and all three factors in girls, while HOMA-IR and
insulin loaded into two factors in boys but only one fac-
tor in girls. This finding may indicate that WC has a
unifying role, more so than HOMA-IR or insulin in the
clustering of MetS, in girls.
The factor structures showed some differences when an-
alyzed together with leptin and adiponectin in girls but
not in boys (Figure 1). Again, three factor structures were
retained which explained 69.2% and 66.6% of the total
variance in boys and girls, respectively. In boys, leptin
loaded positively on the first factor associated with WC,
TG, HDL-C, HOMA-IR and insulin, while adiponectin
loaded negatively on this factor. WC and HOMA-IR still
retained their loadings on two factors. In girls, HOMA-IR,
insulin and glucose still loaded on the first factor; leptin
showed positive loading in both factor 1 and 2, while
adiponectin showed negative loading only in the second
factor together with TG and HDL-C; the unifying role of
WC was still retained, and as it was for leptin if relaxation
of the factor loading threshold to 0.30 was allowed.
Results of factor analysis with only four (WC, MAP, TG/
HDL-C, HOMA-IR) or five parameters (adding leptin/
adiponectin ratio as additional variable) are presented in
Table 5. One-factor model which was extracted in both
genders with or without leptin/adiponectin, explained
61.7% and 55.8%-58% of the total variance in boys and
girls, respectively. In these two models, WC had the
biggest factor loading, while in the one with leptin/
adiponectin, this parameter made the second largest con-
tribution. In addition, after further stratifying for pubertal
stage (prepubertal and pubertal), the one-factor model
was still consistent and explained a similar amount of vari-
ance in both genders (data not shown).
Discussion
Comparison between these two definitions
Because there is still no universally accepted definition
of childhood MetS, pediatric studies have invariably
adapted adult standards in conjunction with use of
gender- and age-dependent normal values(2). In this
study, we applied both the IDF and modified ATPIII def-
initions to the same population to estimate prevalence
of MetS in a sample of overweight and obese children in
Beijing.
Our results show that prevalence of MetS using the
IDF 2007 definition is lower in obese children in Beijing
(14.3%) compared to their counterparts in the USA
(20.8%), Korea (24.3%) [35] and Turkey (31%) [36], but
higher than children in Greece (7.7%) [37]. However,
these estimates should be interpreted with caution since
the various studies were not standardized with respect
to ethnicity, pubertal status, age range, sample size and
collection methods.
Table 4 Factor loadings of conventional variables with leptin and adiponectin on the selected factors
Variable Conventional variables Conventional variables
+leptin + adiponectin
Factor 1 Factor 2 Factor 3 Factor 1 Factor 2 Factor 3
Boys (n = 1717)
WC 0.616 0.557 0.158 0.701 0.495 0.136
SBP 0.246 0.876 0.143 0.287 0.864 0.140
DBP 0.110 0.906 0.087 0.143 0.898 0.110
TG# 0.753 0.095 0.037 0.696 0.060 0.072
HDL-C −0.752 −0.223 0.166 −0.695 −0.213 0.184
Glucose −0.149 0.092 0.831 −0.127 0.118 0.819
HOMA-IR# 0.648 0.210 0.676 0.670 0.171 0.650
Insulin# 0.689 0.207 0.600 0.710 0.163 0.574
Leptin# 0.707 0.160 0.239
Adiponectin# −0.546 −0.237 0.159
Variance explained (%) 31.275 25.651 19.874 33.284 19.987 15.937
Cumulative variance (%) 31.275 56.926 76.800 33.284 53.271 69.208
Girls (n = 1656)
WC 0.419 0.510 0.447 0.425 0.547 0.469
SBP 0.167 0.891 0.093 0.173 0.139 0.877
DBP 0.127 0.891 0.031 0.147 0.059 0.883
TG# 0.180 −0.057 0.763 0.248 0.625 −0.130
HDL-C 0.017 −0.205 −0.805 0.002 −0.759 −0.127
Glucose 0.681 0.018 −0.131 0.670 −0.169 0.035
HOMA-IR# 0.859 0.280 0.321 0.852 0.340 0.246
Insulin# 0.803 0.288 0.356 0.797 0.381 0.250
Leptin# 0.491 0.529 0.350
Adiopnectin# −0.008 −0.614 −0.173
Variance explained (%) 26.228 25.699 21.097 23.449 22.352 20.796
Cumulative variance (%) 26.228 51.927 73.024 23.449 45.801 66.597
Abbreviations: WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, TG triglycerides, HDL-C high-density lipoprotein cholesterol,
HOMA-IR homeostatic model assessment of insulin resistance. #Skewed distributions were logarithmically transformed. Factors with an eigenvalue ≥1 were
selected for analysis. Factor loading ≥ |0.40| are in bold font.
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lence estimated according to the IDF 2007 definition
was significantly lower than the modified ATPIII defin-
ition estimate. It is obvious that the sensitivity of the
IDF definition for diagnosing of MetS is significantly
lower than the modified ATPIII definition, especially in
the overweight and obese groups, because these two def-
initions although included the same components, had
different cut-points for hypertriglyceridemia and ele-
vated blood pressure. In addition, the IDF definition po-
sitions central obesity as an essential element, which
almost rules out the possibility of diagnosing MetS in a
normal weight individual.
Another important discrepancy of these definitions is
that the IDF definition suggests the diagnosis of MetS
not be made for children below the age of 10 years [4].In these children we applied the modified ATPIII criteria
to define MetS and still found a high prevalence among
obese children (21.8%). In addition, as have been
performed in other studies [32], we applied the IDF cri-
teria for children aged 10 to 16 years to this younger
group. Though this may lead to underestimation, we still
found about 6% of obese children meeting the criteria
for MetS. These results show that early-onset MetS is of
concern. Regardless of the definition of MetS, there is
increasing prevalence of MetS features in this young age
group with increasing obesity, with potential long-term
adverse consequences.
It has been reported that diagnosis of childhood MetS
lacked stability. In two previous studies, approximately
half of the adolescents with MetS at baseline no longer
had the diagnosis at follow-up [38,39]. This could be due
Figure 1 Component plots with factor diagrams from
exploratory factor analysis with varimax rotation. Classic
variables, leptin and adiponectin were all included. A, boys
(n = 1717). B, girl (n = 1656).
Table 5 Factor loadings of conventional variables with leptin
Boys (n = 1717)
Conventional variables Conventional va
Leptin/Adipo





Variance explained (%) 61.7 61.7
Abbreviations: WC waist circumference, MAP mean arterial pressure, TG triglycerides
homeostatic model assessment of insulin resistance, Leptin/Adiponectin leptin-to-ad
Factors with an eigenvalue ≥1 were selected for analysis.
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the instability of the clinical features in children which are
used to define MetS in adults. Currently, apart from the
IDF, most pediatric definitions define their components
such as the abnormalities of lipids, BPs on the base of the
age-, sex-specific percentiles rather than absolute numbers
[4,5]. This may result in fluctuation in the individual diag-
nosis of MetS as the child’s clinical parameters develop at a
different rate than the “normal” population. In addition,
without long-term outcomes data, by simply basing the
diagnosis of MetS on predominantly percentile-based cri-
teria will cause problems as the overall population’s clinical
parameters worsen, or improve with time.
Factor structures of MetS
Exploratory factor analysis resolves highly interrelated
variables into a set of unrelated latent factors and is par-
ticularly useful for examining the nature of MetS. In this
study, factor analysis conducted with conventional compo-
nents of MetS led to extraction of three factors in both
genders, which was consistent with previous pediatric
studies [20,21]. Previous factor analysis performed among
934 non-diabetic and 305 diabetic Chinese adults led to ex-
traction of four factors [18]. The factor structures seen in
our study were similar to those seen in adults, suggesting
that similar unfavorable interactions between risk factors
of cardiovascular disease and T2DM are established early
in life [40].
Models with more than one factor are suggestive of
complex etiology of MetS and may appear to contradict
the unity hypothesis [17]. However, a previous study has
pointed out that using two or more measures for the
same trait would ensure that highly correlated measures
cluster together under a separate factor rather than load
on a common factor [23], and studies with a higher
starting number of components tended to produce a lar-
ger number of factors [2,23]. These effects were con-
firmed in this study. With only one measure for each
postulated MetS component, a one-factor model was
also obtained in our study, suggesting that there may/adiponectin on the selected factors among boys and girls
Girls (n = 1656)
riables +
nectin
Conventional variables Conventional variables +
Leptin/Adiponectin






, HDL-C high-density lipoprotein cholesterol, TG/HDL TG-to-HDL ratio, HOMA-IR
iponectin ratio. # Skewed distributions were logarithmically transformed.
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different components of MetS [24,25,27]. Considering
that parameters loading on the same factor are strongly
associated with each other [34], this one-factor model is
therefore not necessarily a contradiction of a three-
factor model that has a larger number of observed vari-
ables. With leptin/adiponectin ratio as an additional
component, the one-factor model was still retained. Pre-
vious studies with one-factor models [24,25,27] differed
from ours in that they all used confirmatory factor ana-
lysis and none of them included leptin/adiponectin as a
variable.
Associations between adipokines and MetS
Leptin and adiponectin are two well-studied adipokines
[7]. However, whether the two adipokines should be con-
sidered as additional MetS components is controversial.
Several studies have conducted factor analysis to provide
support [9-11]. In our study, hyperleptinemia (perhaps
leptin resistance) is common amongst obese children. Fur-
ther, leptin level was associated with insulin resistance and
all other components of MetS. In factor analysis, if the fac-
tor loading threshold used for interpretation was reduced
from 0.4 to 0.3 [17,33], leptin would have loaded onto all
three factors in girls, thus, potentially playing a unifying
role. This result is in contrast to previous studies [9-11].
In a study conducted in Canadian children, leptin loaded
only onto an adiposity factor [41]. In a large adult study
conducted in Mauritius, leptin loaded onto a major factor
containing BMI, WC, insulin, TG and HDL-C [11]. To
our knowledge, no unifying role of leptin has been
reported. However, previous studies have shown that high
plasma leptin level is associated with the development of
essential hypertension, hyperinsulinemia and dyslipidemia
[7,42]. Therefore it should not be surprising that leptin
could align with the lipid, glucose and blood pressure fac-
tors. Furthermore, previous studies were often carried out
in community-based or school-based populations, in which
leptin resistance induced by hyperleptinemia was not com-
monly present and the effect of both hyperleptinemia and
leptin resistance on MetS was not yet apparent. In contrast,
with a large sample of children at risk for MetS from the
BCAMS study, prevalence of overweight and obesity was
much higher than in the general population. This made it
easier to reveal the adverse associations of hyperleptinemia.
As indicated in our study, girls were found to have signifi-
cantly higher leptin concentrations than boys at the same
degree of adiposity [43], and this may partly explain why
the unifying role of leptin was more obvious in girls com-
pared to boys. In addition, when analysis was stratified by
pubertal status, the role of leptin on linking the conven-
tional components of MetS became more apparent in pu-
bertal than in prepubertal children, regardless of their
gender (data not shown).Although secreted predominantly by adipose tissue, con-
centration of adiponectin, unlike that of other adipokines, is
decreased in obesity [6,7]. Adiponectin has properties that
have been characterized as antiatherogenic, antidiabetic,
and anti-inflammatory (7). Hypoadiponectinemia has also
shown to be associated with the occurrence of MetS,
T2DM, hypertension, dyslipidemia and CVD [6,7,12,42].
Although factor structures obtained in previous studies
[13,41] carried out on children and adults showed some dif-
ferences, as with our results, clustering of adiponectin to-
gether with TG and HDL-C is commonly observed. As
with other studies [13,41,44], we found that adiponectin
was significantly related to SBP and DBP in correlation ana-
lysis, but did not load onto the same factor with these vari-
ables. However, unlike leptin, adiponectin loaded only on
one factor suggesting that it may not play a causative role
in the clustering of metabolic abnormalities in children.
Recently, leptin/adiponectin was proposed as a bio-
marker that may serve as a potential atherogenic index in
obese T2DM patients [15], and it provides adjunctive in-
formation to the risk of MS beyond the HOMA-IR [16].
In our one-factor model, leptin/adiponectin was, after
WC, the second highest factor loading, followed by
HOMA-IR, MAP or TG/HDL-C. Moreover, this one-
factor model was not altered after stratification by puber-
tal status, and thus appeared to be consistent across sex
and puberty. This finding is consistent with another recent
report, which also revealed the stability of the one-factor
structure of MetS from childhood to adolescence during a
6-year follow-up study [45]. Therefore, pubertal develop-
ment may have impact on adipokine secretion [46], but
may not affect the stability of a single-factor model of
MetS with leptin/adiponectin as a variable.
Our factor analysis results suggest that leptin/adiponectin
should be considered a component of MetS. However, fur-
ther follow up studies of leptin, adiponectin and their ratio
in children and adolescents are needed to determine if they
could (i) be predictors of MetS in adulthood, (ii) increase
the stability of MetS diagnosis in children and (iii)
provide additive value to predicting future cardiovascular
morbidity.
Associations between WC and MetS
Apart from glucose, WC was associated with all MetS
risk factors, and its correlation with most of these vari-
ables was much stronger than HOMA-IR. With or with-
out adipokines as variables, WC loaded onto the first
two factors in boys and all three factors in girls, while
HOMA-IR loaded onto only two factors in boys and one
in girls. In the one-factor model, WC contributed most
(with highest loading factor), while HOMA-IR contrib-
uted less. HOMA-IR contributed less than leptin/
adiponectin ratio. These results implicate that central
obesity in children plays a more important role in
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and that insulin resistance may be causally downstream
of central obesity [47], supporting the IDF 2007 defin-
ition that central obesity should be taken as the essential
element in MetS. Our results are compatible with the
theory that MetS is related primarily to dysregulation of
adipose tissue [47]. Visceral fat accumulation results in
adipose tissue dysfunction, which in turn leads to over
secretion of deleterious adipokines and hyposecretion of
beneficial adipokines such as adiponectin. This may be
one of the major underlying mechanisms in obesity-
related diseases [7], explaining the clustering of WC to-
gether with hyperleptinemia and hypoadiponectin.
Identifying high risk children is important to help pre-
vent them from future development of MetS. As an an-
thropometric measurement which is easy to perform,
there is no doubt that WC would be a good tool for
screening children at risk of MetS [4]. However, some
concerns remain. First, it should be noted that even
normal-weight individuals may develop features of MetS.
This makes it difficult to identify the appropriate cut-
points for WC above which it would be considered a
risk factor. Second, although abdominal obesity can be
easily assessed using the simple measure of WC, other
complex measures such as the body fat distribution (by
dual energy X-ray absorptiometry or magnetic resonance
imaging), or adipose tissue biomarkers such as leptin
and adiponectin, may be appropriate surrogate markers
of central obesity and should play an important role in
childhood MetS research [4]. Notably, since unfavorable
changes in secretion of adipokines, such as elevated lep-
tin/adiponectin ratio, can directly reflect adipose tissue
dysfunction and these changes may precede and predict
obesity-related metabolic disorders [7], WC in conjunc-
tion with leptin/adiponectin may more accurately iden-
tify abnormal fat distribution and function in children
and thus predict their risk of MetS at an earlier stage
[48]. Future longitudinal studies are warranted to study
these postulations.
Conclusion
In this study, prevalence of MetS in normal weight,
overweight and obese children in Beijing was estimated
according to the IDF 2007 and modified ATPIII defini-
tions. Comparisons were made between these defini-
tions. For children ≥10 years, prevalence of MetS was
14.3% in the obese group and 3.7% in the overweight
group according to the IDF definition. Factor structures
of MetS with and without adipokines were investigated
with exploratory factor analysis. To our knowledge, this
is the first study to incorporate leptin/adiponectin ratio
as an additional MetS component in a one-factor model
and show that it outperforms other clinical and bio-
chemical parameters.This study has some limitations, which need to be con-
sidered. First, the cross-sectional design of limited our abil-
ity to comment on causal associations between the factors
studied. Our ongoing follow-up study is expected to over-
come this problem. Second, although a hyperinsulinemic
euglycemic clamp is the gold standard method to assess in-
sulin sensitivity, it was not practical in a large sample such
as this. However, in a previous study, it has been demon-
strated that fasting insulin and WC together gave results
similar to insulin sensitivity measured directly by the
hyperinsulinemic euglycemic clamp [20], and these two
variables have been well measured in our study.
In conclusion, our results show that prevalence of MetS
in overweight/obese children older than 10 years is high,
regardless of the definition used. Furthermore, metabolic
abnormality in children under 10 years is also worthy of
concern. Factor analysis shows that central obesity is the
key factor in the clustering of metabolic risk factors, while
hyperleptinemia provides a connection between the differ-
ent factors underlying the MetS. We suggest using leptin/
adiponectin as a component of MetS. Finally, in our study
a single factor has been suggested to underlie the MetS
construct in Chinese children and adolescents, suggesting
that there could be some pattern of common causation
for the clustering of MetS components.
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